Ingredion (INGR) Reiterated at Buy by Benchmark Amid Tate & Lyle Bid Announcement

June 9, 2026 7:24 AM

Benchmark analyst Benjamin Klieve reiterated a Buy rating and $130.00 price target on Ingredion (NYSE: INGR).The analyst commented, "A rumored ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found